Neurology

Explore some of the most highly anticipated clinical trials with data readouts expected in the…

The submission was based on promising data from a phase 3 and phase 2 study,…

A duo of experts discussed the importance of addressing barriers such as provider comfort, access…

The William S. and Lois Stiles Edgerly Professor of Neurology at Yale School of Medicine…

The neurointensivist and assistant professor of neurology at Boston Medical Center gave insight on a…

Early initiation of combined low‐dose rituximab therapy showed better improvements of chronic inflammatory demyelinating polyradiculoneuropathy…

The U.S. HHS announced 15 drugs, including deutetrabenazine, will undergo Medicare Part D price negotiations…

Neurologists Steven Lewis, MD, and Behrang Saminejad, MD, of Lehigh Valley Health Network, provided commentary…

Amaza Reitmeier and Ashwini Sharan, MD, gave clinical perspectives on the CE Mark approval for…

Previously, Argenx's efgartigimod alfa and hyaluronidase-qvfc was granted orphan drug designation for the treatment of…